Future Outlook of Kidney Cancer Treatment
Expert oncologists offer closing thoughts on emerging therapeutic strategies, unmet needs, and the future of kidney cancer treatment.
Treating Patients With Non–Clear Cell Renal Cell Carcinoma
Tian Zhang, MD, MHS, provides an overview of the treatment of patients with non–clear cell renal cell carcinoma.
Combination Immunotherapy for Treating Advanced Renal Cell Carcinoma
An overview of the treatment protocol for patients with advanced RCC who are receiving IO/TKI or IO/IO combination therapy.
Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies
Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.
Selecting Appropriate Treatments for Patients With Advanced RCC
Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.
Systemic Therapies in Advanced Renal Cell Carcinoma
A comprehensive overview of systemic therapies available for the treatment of patients with advanced renal cell carcinoma.
Renal Cell Carcinoma Prognosis and Risk Stratification
Experts in the field of kidney cancer discuss the risk stratification process for renal cell carcinoma and its effect on prognosis.
Diagnosing Renal Cell Carcinoma
Clinical insights on the typical presentation of kidney cancer and the diagnostic process.
Overview of Kidney Cancer
Chandler H. Park, MD, and Tian Zhang, MD, MHS, give an overview of renal cell carcinoma (RCC) and outline disease risk factors, symptoms, and prevention strategies.
2 Clarke Drive Cranbury, NJ 08512